Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy

ClinicalTrials.gov ID: NCT00469729

Public ClinicalTrials.gov record NCT00469729. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 20, 2026, 1:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Multi-National, Historical Cohort Controlled Study to Evaluate Efficacy and Safety of Transplantation of StemEx®, Umbilical Cord Blood Stem and Progenitor Cells Expanded Ex Vivo, in Subjects With Hematologic Malignancies Following Myeloablative Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the efficacy and safety of transplanting StemEx® in patients with certain hematological malignancies. For these patients, it is suggested that StemEx® can improve upon the outcome of transplanting a single, unmanipulated cord blood unit by significantly increasing the number of stem/progenitor cells available to the patient.

Study identification

NCT ID: NCT00469729
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2, Phase 3
Lead sponsor: Gamida Cell -Teva Joint Venture Ltd.; Other
Enrollment: 101 participants

Conditions and interventions

Conditions

Interventions

StemEx® Drug

Drug

Eligibility (public fields only)

Age range: 12 Years to 55 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 2007 (Type not available)
Primary completion: Feb 2013 (Actual)
Completion: Jun 2015 (Actual)
Last update posted: Jul 10, 2015

2007 – 2015

United States locations

U.S. sites: 16
U.S. states: 10
U.S. cities: 13

Facility	City	State	ZIP	Site status
UCLA's Jonsson Comprehensive Cancer Center	Los Angeles	California	90095-1781	—
Children's Hospital of Orange County	Orange	California	92868-3874	—
The Children's Hospital, B115, University of Colorado Health Sciences Center	Aurora	Colorado	80045	—
Northwestern University School of Medicine, Stem Cell Transplant Program, Children's Memorial Hospital	Chicago	Illinois	60614	—
Cardinal Bernardin Cancer Center, Loyola University Stritch School of Medicine	Maywood	Illinois	60153	—
The Cancer Center at Hackensack University Medical Center	Hackensack	New Jersey	07601	—
Cornell University, Joan & Sanford I. Weill Medical College	New York	New York	NY 10065	—
Steven and Alexandra Cohen Children's Medical Center of New York	New York	New York	—	—
Mount Sinai Medical Center	One Gustave L Levy Place, BOX 1410, New York	New York	10029	—
Case Western Reserve University	Cleveland	Ohio	44106	—
The Western Pennsylvania Hospital	Pittsburgh	Pennsylvania	15224	—
University of Pittsburgh Cancer Institute/UPMC Cancer Centers	Pittsburgh	Pennsylvania	15232	—
Texas Transplant Institute	San Antonio	Texas	78229	—
University of Virginia, Hematopoietic Stem Cell Transplant Program	West Complex 1300 Jefferson Park Av, Charlottesville	Virginia	22903	—
Medical College of Wisconsin Division of Neoplastic Diseases and Related Disorders	Milwaukee	Wisconsin	53226	—
Medical College of Wisconsin Pediatric Blood and Marrow Transplant Program	Milwaukee	Wisconsin	53226	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00469729, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 10, 2015 · Synced Oct 20, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00469729 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →